Single-tablet regimens for HIV: Difference between revisions

From IDWiki
No edit summary
(Redirected page to HIV medications)
Tag: New redirect
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
#REDIRECT [[HIV medications#Single-Tablet Regimens]]
See also [[HIV treatment]]

{|
! Brand name
! NRTIs
! Non-NRTI
! Notes
|-
| Triumeq
| abacavir / lamivudine
| dolutegravir (INI)
| Highest barrier to resistance. Need to test for HLA-B5701 allele before starting. Avoid in hepatitis B coinfection.
|-
| Atripla
| tenofovir disoproxil / emtricitabine
| efavirenz
| Older regimen. Neuropsychiatric symptoms, possibly including suicide.
|-
| Complera
| tenofovir disoproxil / emtricitabine
| rilpivirine
| Avoid with viral loads (>100,000) or low CD4 (<200). Pill must be taken with food (>400kcal) and without PPIs.
|-
| Stribild
| tenofovir disoproxil / emtricitabine
| elvitegravir/cobicistat (INI)
| Includes a P450 inhibitor to boost elvitegravir levels, with resultant drug-drug interactions. Avoid if CrCl <70.
|-
| Biktarvy
| FTC/TAF
| BIC
|
|}

[[Category:HIV]]
[[Category:Antivirals]]

Latest revision as of 22:23, 4 February 2020

Redirect to: